BAX (Baxter Corp) רווח למניה בשנים עשר החודשים האחרונים

The rolling annual net income per share demonstrates the dominance of Baxter International (BAX) in the supply of hospital systems and nutrition. However, biotech startups offering home-based therapy methods are creating pressure. The value of -1.39 shapes the current metric. Steady growth confirms the status of a brand trusted by medical professionals worldwide for the high quality of its critical care equipment.

For Baxter International (BAX), annual net income per share serves as an indicator of the efficiency of capital structure optimization through the spin-off of Vantive and the development of the high-tech hospital segment. This metric reflects the company's bottom line divided by the total number of securities, allowing investors to assess the real profitability of the business, stripped of the impact of issuance and debt obligations.